The Similarity of a Critical Quality Study Among the Ciplukan Extract Capsule from A Laboratory Setting and a Pilot Scale in a Partner Industry
Journal of Reports in Pharmaceutical Sciences · 2025
DOI: 10.5812/jrps-154434 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Reports in Pharmaceutical Sciences, 2025. Verfasst von Yoga Windhu Wardhana und 8 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Differences in pharmaceutical product processing and equipment between laboratory development and industrial scale-up can result in dramatically variable quality. Therefore, the quality similarities across pharmaceutical dosage forms must be tested at several facilities. Similarities in the quality of dosage forms for pharmacological treatment derived from herbal ingredients from development and production scale are often overlooked, and no one has published them yet.
Methods
A two-level factorial experimental design was used in the laboratory for formulation optimization, with variations in the composition of colloidal silicon dioxide and starch glycolate salts. Quality responses included loss on drying (LOD), flowability, angle of repose, uniformity of capsule weight, and disintegration time. The same responses as the performance of similarity attributes were also evaluated on pilot-scale items from partner businesses.
Results
The overall quality response of the tested product met the standards for fine granules and capsules. The composition with the highest attractiveness, according to the program, was F4 at 0.686, based on a pilot-scale formulation at partner industrial facilities. According to a Jaccard similarity of 0.88, the quality test results were quite comparable. A total plate number test was performed to assess the safety of microbiological contamination throughout the processing of all goods, yielding a result of 7.07 × 104, which is still in conformity with the standards of the Indonesian Food and Drug Administration (FDA), namely 107.
Conclusions
The Jaccard similarity index for capsule manufacture at two different manufacturing sites is 0.88, indicating an excellent resemblance. This suggests that the process may be repeated in larger quantities.
Zitieren
APA
Wardhana, Y. W., Indradi, R. B., Zuhrotun, A., Hendriani, R., Rohmawaty, E., Saragih, W., Ekawardhani, S., Wiraswati, H. L., & Dewi, S. (2025). The Similarity of a Critical Quality Study Among the Ciplukan Extract Capsule from A Laboratory Setting and a Pilot Scale in a Partner Industry. Journal of Reports in Pharmaceutical Sciences. https://doi.org/10.5812/jrps-154434
Vancouver
Wardhana YW, Indradi RB, Zuhrotun A, Hendriani R, Rohmawaty E, Saragih W, et al. The Similarity of a Critical Quality Study Among the Ciplukan Extract Capsule from A Laboratory Setting and a Pilot Scale in a Partner Industry. Journal of Reports in Pharmaceutical Sciences. 2025. doi:10.5812/jrps-154434
BibTeX
@article{Wardhana2025,
author = {Wardhana, Yoga Windhu and Indradi, Raden Bayu and Zuhrotun, Ade and Hendriani, Rini and Rohmawaty, Enny and Saragih, Winda and Ekawardhani, Savira and Wiraswati, Hesti Lina and Dewi, Sumartini},
title = {The Similarity of a Critical Quality Study Among the Ciplukan Extract Capsule from A Laboratory Setting and a Pilot Scale in a Partner Industry},
journal = {Journal of Reports in Pharmaceutical Sciences},
year = {2025},
doi = {10.5812/jrps-154434}
}
EUVIMED